CPT Codes 0817T and 0988T For CY 2024, the CPT Editorial Panel established four new Category III CPT codes, specifically, CPT codes 0816T, 0817T, 0818T, and 0819T to describe integrated neurostimulation services for bladder dysfunction, effective January 1, 2024
Key considerations include: Lack of standardized dosing guidelines Limited long-term safety data Variability in manufacturing quality Anyone considering experimental therapies should do so under appropriate medical guidance
Localized delivery: For research examining local tissue effects (e.g., muscle healing), IM injection delivers the peptide directly to the target tissue
Each capsule contains 250mcg of BPC-157, the 15-amino acid synthetic peptide studied for its tissue-protective and regenerative properties in preclinical models
While it is not naturally produced, it is present in many foods including animal produce and seafood and can also be received through supplements
A small fraction of users (under 5 percent) report mild anxiety alongside sleep disruption in the first week of dosing